NCT00001997View on ClinicalTrials.gov

Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals

NACompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Interleukin-2, Polyethylene Glycolated

DRUG

Zidovudine

DRUG

Didanosine

Trial Locations (1)

94108

Dr David R Senechek, San Francisco

Sponsors

Lead Sponsor

Chiron Corporation

All Listed Sponsors

lead

Chiron Corporation

INDUSTRY

NCT00001997 - Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals | Biotech Hunter | Biotech Hunter